Literature DB >> 21273004

An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses.

Stephanie H Witt1, Arlette F Buchmann, Dorothea Blomeyer, Vanessa Nieratschker, Jens Treutlein, Günter Esser, Martin H Schmidt, Martin Bidlingmaier, Klaus Wiedemann, Marcella Rietschel, Manfred Laucht, Stefan Wüst, Ulrich S Zimmermann.   

Abstract

Interindividual variability in the regulation of the human stress system accounts for a part of the individual's liability to stress-related diseases. These differences are influenced by environmental and genetic factors. Early childhood adversity is a well-studied environmental factor affecting an individual's stress response which has been shown to be modulated by gene-environment interaction (GxE). Neuropeptide Y (NPY) plays a role in stress regulation and genetic variation in NPY may influence stress responses. In this study, we analyzed the association of a common variant in the NPY gene promoter, rs16147, with cortisol and ACTH responses to acute psychosocial stress in young adults from the Mannheim Study of Children at Risk (MARS), an ongoing epidemiological cohort study following the outcome of early adversity from birth into adulthood. We found evidence of a GxE interaction between rs16147 and early adversity significantly affecting HPA axis responses to acute psychosocial stress. These findings suggest that the neurobiological mechanisms linking early adverse experience and later neuroendocrine stress regulation are modulated by a gene variant whose functional relevance is documented by increasing convergent evidence from in vitro, animal and human studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273004     DOI: 10.1016/j.psyneuen.2010.12.015

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  21 in total

Review 1.  Differential Susceptibility of the Developing Brain to Contextual Adversity and Stress.

Authors:  W Thomas Boyce
Journal:  Neuropsychopharmacology       Date:  2015-09-22       Impact factor: 7.853

Review 2.  The National Health and Resilience in Veterans Study: A Narrative Review and Future Directions.

Authors:  Brienna M Fogle; Jack Tsai; Natalie Mota; Ilan Harpaz-Rotem; John H Krystal; Steven M Southwick; Robert H Pietrzak
Journal:  Front Psychiatry       Date:  2020-12-09       Impact factor: 4.157

3.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

4.  Genetic load is associated with hypothalamic-pituitary-adrenal axis dysregulation in macaques.

Authors:  B Ferguson; J E Hunter; J Luty; S L Street; A Woodall; K A Grant
Journal:  Genes Brain Behav       Date:  2012-10-13       Impact factor: 3.449

5.  Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder.

Authors:  Renu Sah; Nosakhare N Ekhator; Lena Jefferson-Wilson; Paul S Horn; Thomas D Geracioti
Journal:  Psychoneuroendocrinology       Date:  2013-11-05       Impact factor: 4.905

6.  Interaction between prenatal stress and dopamine D4 receptor genotype in predicting aggression and cortisol levels in young adults.

Authors:  Arlette F Buchmann; Katrin Zohsel; Dorothea Blomeyer; Erika Hohm; Sarah Hohmann; Christine Jennen-Steinmetz; Jens Treutlein; Katja Becker; Tobias Banaschewski; Martin H Schmidt; Günter Esser; Daniel Brandeis; Luise Poustka; Ulrich S Zimmermann; Manfred Laucht
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

7.  Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial.

Authors:  Xiaomin Zhang; Qibin Qi; Jun Liang; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Hypertension       Date:  2012-09-10       Impact factor: 10.190

8.  NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.

Authors:  Andrei I Molosh; Tammy J Sajdyk; William A Truitt; Weiguo Zhu; Gerry S Oxford; Anantha Shekhar
Journal:  Neuropsychopharmacology       Date:  2013-01-28       Impact factor: 7.853

Review 9.  Toward an integration of cognitive and genetic models of risk for depression.

Authors:  Brandon E Gibb; Christopher G Beevers; John E McGeary
Journal:  Cogn Emot       Date:  2012-08-24

10.  The influence of infant-caregiver experiences on amygdala Bdnf, OXTr, and NPY expression in developing and adult male and female rats.

Authors:  Kathryn T Hill; Megan Warren; Tania L Roth
Journal:  Behav Brain Res       Date:  2014-07-08       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.